15-Lipoxygenase-2 (15-LOX-2) Is Expressed in Benign Prostatic Epithelium and Reduced in Prostate Adenocarcinoma
- 1 July 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (1) , 235-245
- https://doi.org/10.1016/s0002-9440(10)65117-6
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Defense (PC970260, GM-53638)
- National Institutes of Health (PC970260, GM-53638)
This publication has 38 references indexed in Scilit:
- Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγCell, 1998
- Production of 13-Hydroxyoctadecadienoic Acid (13-HODE) by Prostate Tumors and Cell LinesBiochemical and Biophysical Research Communications, 1997
- Arachidonic Acid Stimulates Prostate Cancer Cell Growth: Critical Role of 5-LipoxygenaseBiochemical and Biophysical Research Communications, 1997
- Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.Journal of Clinical Investigation, 1997
- The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient miceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- 12-Lipoxygenase, 12(S)-HETE, and Cancer MetastasisAnnals of the New York Academy of Sciences, 1994
- Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitorsInternational Journal of Cancer, 1994
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987